Unknown

Dataset Information

Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes.


ABSTRACT:

Objective

To evaluate the comparative safety and adjunctive efficacy of pregabalin and gabapentin in reducing seizure frequency in patients with partial-onset seizures based on prestudy modeling showing superior efficacy for pregabalin.

Methods

The design of this comparative efficacy and safety study of pregabalin and gabapentin as adjunctive treatment in adults with refractory partial-onset seizures was randomized, flexible dose, double blind, and parallel group. The study included a 6-week baseline and a 21-week treatment phase. The primary endpoint was the percentage change from baseline in 28-day seizure rate to the treatment phase.

Results

A total of 484 patients were randomized to pregabalin (n = 242) or gabapentin (n = 242). Of these, 359 patients (187 pregabal

SUBMITTER: French J 

PROVIDER: S-EPMC5035985 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature